These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2424454)

  • 21. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
    Sanz-Moncasi MP; Garin-Chesa P; Stockert E; Jaffe EA; Old LJ; Rettig WJ
    Lab Invest; 1994 Sep; 71(3):366-73. PubMed ID: 7933987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The development of endothelial cell-to-cell junctions].
    Wang XJ; Yang ZC
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):314-8. PubMed ID: 12501659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endothelial junctions: exploiting their instability in the development of biomarkers for vascular remodelling].
    Bouillet L; Sidibé A; Polena H; Mannic T; Deroux A; Stidder B; Vittecoq O; Vilgrain I
    Med Sci (Paris); 2014; 30(6-7):633-5. PubMed ID: 25014453
    [No Abstract]   [Full Text] [Related]  

  • 25. Neovasculature induced by vascular endothelial growth factor is fenestrated.
    Roberts WG; Palade GE
    Cancer Res; 1997 Feb; 57(4):765-72. PubMed ID: 9044858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular damage and tumour response.
    Murray JC
    Eur J Cancer; 1992; 28A(10):1593-4. PubMed ID: 1389469
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy.
    Cemazar M; Parkins CS; Holder AL; Chaplin DJ; Tozer GM; Sersa G
    Br J Cancer; 2001 Feb; 84(4):565-70. PubMed ID: 11207055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville.
    Fingar VH; Taber SW; Haydon PS; Harrison LT; Kempf SJ; Wieman TJ
    In Vivo; 2000; 14(1):93-100. PubMed ID: 10757064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial filaments and intercellular gaps--a sufficient evidence for contractility?
    Hammersen F
    Bibl Anat; 1973; 12():159-64. PubMed ID: 4597631
    [No Abstract]   [Full Text] [Related]  

  • 31. Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro.
    Nuver J; De Haas EC; Van Zweeden M; Gietema JA; Meijer C
    Oncol Rep; 2010 Jan; 23(1):247-53. PubMed ID: 19956889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional characteristics of the microcirculation in neoplasms.
    Papadimitrou JM; Woods AE
    J Pathol; 1975 Jun; 116(2):65-72. PubMed ID: 168332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of injury and repair of the pulmonary endothelium on lung metastasis after bleomycin.
    Adamson IY; Orr FW; Young L
    J Pathol; 1986 Dec; 150(4):279-87. PubMed ID: 2433421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection by flunarizine against endothelial cell injury in vivo.
    Hladovec J; De Clerck F
    Angiology; 1981 Jul; 32(7):448-62. PubMed ID: 7247070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endoendothelial layer of normal and injured vascular endothelium--an electron microscope study.
    Sztynda T; Hurley JV
    J Pathol; 1984 Mar; 142(3):181-94. PubMed ID: 6200588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
    ten Hagen TL; Seynhaeve AL; Eggermont AM
    Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary toxicity of antineoplastic drugs.
    Batist G; Andrews JL
    JAMA; 1981 Sep; 246(13):1449-53. PubMed ID: 7265453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bleomycin: cellular and vascular alteration in a patient (author's transl)].
    Hagedorn M; Petres J; Mittermayer C
    Arch Dermatol Forsch; 1974 Jul; 250(1):71-80. PubMed ID: 4136308
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary toxicity of antineoplastic drugs.
    Willson JK
    Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
    Moeller BJ; Batinic-Haberle I; Spasojevic I; Rabbani ZN; Anscher MS; Vujaskovic Z; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):545-52. PubMed ID: 16168847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.